Recombinant TNFRSF8 (Brentuximab Biosimilar) antibody

Catalog No. ABIN6964430

This Mouse Chimeric antibody specifically detects TNFRSF8 (Brentuximab Biosimilar) in ELISA. It exhibits reactivity toward Human.

Quick Overview for Recombinant TNFRSF8 (Brentuximab Biosimilar) antibody (ABIN6964430)

Target: TNFRSF8 (Brentuximab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Mouse

Clonality: Chimeric

Conjugate: This TNFRSF8 (Brentuximab Biosimilar) antibody is un-conjugated

Application: ELISA

Grade: Research Grade

Product Details anti-TNFRSF8 (Brentuximab Biosimilar) Antibody

Purpose: Anti-CD30 (brentuximab biosimilar) mAb

Characteristics: SGN-35, cAC10-Val-Cit-MMAE

Purification: Purified from cell culture supernatant by affinity chromatography

Isotype: IgG1

Application Details

Application Notes: ELISA 1:5000-10000

Comment:

Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.

Restrictions: For Research Use only

Handling

Format: Lyophilized

Reconstitution: Reconstitute with deionized water

Buffer: Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8 % trehalose is added as protectants before lyophilization.

Storage: -20 °C,-80 °C

Storage Comment: Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized proteins are shipped at ambient temperature.

Expiry Date: 12 months

Target Details for TNFRSF8 (Brentuximab Biosimilar)

Target: TNFRSF8 (Brentuximab Biosimilar)

Alternative Name: CD30 (Brentuximab Biosimilar)

Target Type: Biosimilar

Background: Synonyms: TNFRSF8,CD30,D1S166E,Ki-1

UniProt: P28908